Association between Consumption of Fluoroquinolones and Carbapenems and Their Resistance Rates in <i>Pseudomonas aeruginosa</i> in Argentina

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Type of fluoroquinolone</td><td class="align_center">Consumption level</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Ciprofloxacin</td><td class="align_center">0.7838</td></tr><tr><td class="align_left">Levofloxacin</td><td class="align_center">0.51</td></tr><tr><td class="align_left">Moxifloxacin</td><td class="align_center">0.0065</td></tr><tr><td class="align_left">Norfloxacin</td><td class="align_center">0.1410</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>Consumption during 2018 was measured as defined daily dose by each 1000 inhabitant.<br/></div></td></tr></table>

<div>Level of global fluoroquinolone consumption according to the drug type during 2018.</div>

Interdisciplinary Perspectives on Infectious Diseases

tab2

Table 2

Table 2: Association between Consumption of Fluoroquinolones and Carbapenems and Their Resistance Rates in <i>Pseudomonas aeruginosa</i> in Argentina 

Interdisciplinary Perspectives on Infectious Diseases

Association between Consumption of Fluoroquinolones and Carbapenems and Their Resistance Rates in Pseudomonas aeruginosa in Argentina

Table 2